Population pharmacokinetics of theophylline in adult Chinese patients with asthma and chronic obstructive pulmonary disease

International Journal of Clinical Pharmacy
Yanjiao MaL Q Wang

Abstract

Background Theophylline has a narrow therapeutic range and large interindividual variability in blood levels, so a thorough understanding of its pharmacokinetic characteristics is essential. Population pharmacokinetic (PPK) approaches could achieve it and many PPK studies of theophylline have been reported in infants. However, none was conducted in Chinese adults and none has explored the effect of CYP1A2 genotypes on the PPK characteristics of theophylline in adults. Objective To evaluate the PPK characteristics of theophylline and to assess the possible influence of covariates, including CYP1A2 genotypes, on theophylline clearance in Chinese adult patients. Setting The study is conducted at the department of respiration in Zhujiang Hospital, Guangzhou, China. Methods Theophylline concentrations were obtained from eligible patients and were measured by high performance liquid chromatography. The polymorphisms of - 3860G > A, - 163C > A, C5347T (CYP1A2*1B) and G-3113A were genotyped using a direct sequencing method. Then, CYP1A2 genotypes, age, fat-free mass (FFM) and other covariates were used to develop a PPK model by NONMEM software. Bootstrap analysis was used to asses the accuracy and prediction of the PPK model. Main outc...Continue Reading

References

Jul 1, 1978·The Journal of Allergy and Clinical Immunology·R A LandayJ C Taylor
Apr 1, 1989·Journal of Pharmacokinetics and Biopharmaceutics·M S DriscollL C Littlefield
Apr 1, 1985·Clinical Pharmacology and Therapeutics·W Y AuN DeSoyza
Jul 17, 1995·Biochemical Pharmacology·Z Y Zhang, L S Kaminsky
Apr 1, 1996·Journal of Clinical Pharmacy and Therapeutics·M J OteroA Dominguez-Gil
Jun 1, 1997·Journal of Clinical Pharmacology·E I Ette
Feb 24, 2001·Clinical Therapeutics·S E MøllerP E Rolan
Jun 19, 2002·Proceedings of the National Academy of Sciences of the United States of America·Kazuhiro ItoPeter J Barnes
May 7, 2003·Clinical Pharmacology and Therapeutics·Yasushi ObaseShigeru Kohno
Sep 1, 2005·Basic & Clinical Pharmacology & Toxicology·Mirko S FaberUwe Fuhr
Dec 31, 2005·European Journal of Clinical Pharmacology·Keiji TakataKazuko Nakagawa
Jul 15, 2006·European Journal of Clinical Pharmacology·Yeomin YoonJunghan Song
Dec 21, 2006·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Tatsuki FukamiTsuyoshi Yokoi
Mar 3, 2009·Drug Metabolism and Pharmacokinetics·Brian J Anderson, Nick H G Holford
Jul 2, 2009·The European Respiratory Journal·B G Cosio, J B Soriano
Jan 15, 2011·European Journal of Clinical Pharmacology·Tony AntoniouDavid N Juurlink
Jan 20, 2012·European Journal of Clinical Pharmacology·David R Plowchalk, Karen Rowland Yeo
Nov 22, 2012·Basic & Clinical Pharmacology & Toxicology·Liqing WangZe-Neng Cheng
Nov 28, 2012·Clinical Pharmacokinetics·Amélie MarsotNicolas Simon
May 16, 2013·American Journal of Respiratory and Critical Care Medicine·Peter J Barnes
Jun 19, 2013·The AAPS Journal·Kelong HanRaman Venkataramanan
Nov 22, 2013·Asia Pacific Allergy·Eun-Young YimSang-Heon Cho

❮ Previous
Next ❯

Related Concepts

Related Feeds

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.